The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): 30m
Expected first date of trading: 16/09/2013
Market: AIM
Location of address at which admission document will be available: The Admission Document, which contains full details about the applicant and the admission of its securities, will be available on the Company's website (www.netscientific.net) in accordance with AIM Rule 26. Copies of the Admission Document will be available for inspection during usual business hours on any day (Saturdays, Sundays and public holidays excepted) at the offices of Simmons & Simmons LLP, CityPoint, One Ropemaker Street, London EC2Y 9SS for a period of 14 days from the date of Admission.
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): Liberum Capital Limited
Nominated Broker (AIM Companies): Liberum Capital Limited
Financial PR Advisors: -

Company details
Name Role
Sir Richard Brook Sykes Non-Executive Chairman
Farad Azima Chief Executive Officer
Michael Thomas Boyce-Jacino Chief Operating Officer
David Anthony Gough Chief Technology Officer
Peter Young Thoms Chief Financial Officer
Nicholas Charles Heckford Director, Commercial and Legal
Barry Woodrow Wilson Non-Executive Director
Lady Barbara Singer Judge Non-Executive Director

Facts and Figures
Fiscal year end: 31 December
Incorporated in: United Kingdom
Website URL: www.netscientific.net
space
Description of business:
NetScientific is a healthcare medical technology ("MedTech") company that identifies, develops and commercialises research and technologies originating from leading universities, teaching hospitals and research institutes globally, particularly in the United Kingdom and the United States. The Group is primarily focused on identifying and developing research and technologies for use in five chronic...

Person(s) interested:
Before Admission: Zahra Holdings Limited 68.8% Quantadyne Limited 20.0% Cyrus Holdings Limited 11.2% After Admission: Invesco Asset Management Limited 39.0% Zahra Holdings Limited 32.9% Quantadyne Limited 9.6% Cyrus Holdings Limited 5.4% Artemis Fund Managers Limited 3.0%


NetScientific plc

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds